This study aimed to investigate the gene polymorphisms of HPA-1 and HPA-5 in Glanzmann Thrombasthenia patients with resistance to platelet therapy and recombinant factor VII compared with the control group in Southeast of Iran. This evidence concerns the gene F7 and Glanzmann thrombasthenia.